|
1
|
Rhodes A, Evans LE, Alhazzani W, Levy MM,
Antonelli M, Ferrer R, Kumar A, Sevransky JE, Sprung CL, Nunnally
ME, et al: Surviving sepsis campaign: International guidelines for
management of sepsis and septic shock: 2016. Intensive Care Med.
43:304–377. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Singer M, Deutschman CS, Seymour CW,
Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche
JD, Coopersmith CM, et al: The third international consensus
definitions for sepsis and septic shock (Sepsis-3). JAMA.
315:801–810. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fleischmann C, Scherag A, Adhikari NK,
Hartog CS, Tsaganos T, Schlattmann P, Angus DC and Reinhart K;
International Forum of Acute Care Trialists, : Assessment of global
incidence and mortality of hospital-treated sepsis. Current
estimates and limitations. Am J Respir Crit Care Med. 193:259–272.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Angus DC and van der Poll T: Severe sepsis
and septic shock. N Engl J Med. 369:20632013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mira JC, Gentile LF, Mathias BJ, Efron PA,
Brakenridge SC, Mohr AM, Moore FA and Moldawer LL: Sepsis
pathophysiology, chronic critical illness, and persistent
inflammation-immunosuppression and catabolism syndrome. Crit Care
Med. 45:253–262. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
van der Poll T, van de Veerdonk FL,
Scicluna BP and Netea MG: The immunopathology of sepsis and
potential therapeutic targets. Nat Rev Immunol. 17:407–420. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rivers E, Nguyen B, Havstad S, Ressler J,
Muzzin A, Knoblich B, Peterson E and Tomlanovich M; Early
Goal-Directed Therapy Collaborative Group, : Early goal-directed
therapy in the treatment of severe sepsis and septic shock. N Engl
J Med. 345:1368–1377. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Godinjak A, Iglica A, Rama A, Tančica I,
Jusufović S, Ajanović A and Kukuljac A: Predictive value of SAPS II
and APACHE II scoring systems for patient outcome in a medical
intensive care unit. Acta Med Acad. 45:97–103. 2016.PubMed/NCBI
|
|
9
|
Iyer MK, Niknafs YS, Malik R, Singhal U,
Sahu A, Hosono Y, Barrette TR, Prensner JR, Evans JR, Zhao S, et
al: The landscape of long noncoding RNAs in the human
transcriptome. Nat Genet. 47:199–208. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ponting CP, Oliver PL and Reik W:
Evolution and functions of long noncoding RNAs. Cell. 136:629–641.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ji P, Diederichs S, Wang W, Böing S,
Metzger R, Schneider PM, Tidow N, Brandt B, Buerger H, Bulk E, et
al: MALAT-1, a novel noncoding RNA, and thymosin beta4 predict
metastasis and survival in early-stage non-small cell lung cancer.
Oncogene. 22:8031–8041. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang X, Hamblin MH and Yin KJ: The long
noncoding RNA Malat1: Its physiological and pathophysiological
functions. RNA Biol. 14:1705–1714. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lipovich L, Dachet F, Cai J, Bagla S,
Balan K, Jia H and Loeb JA: Activity-dependent human brain
coding/noncoding gene regulatory networks. Genetics. 192:1133–1148.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Watts R, Johnsen VL, Shearer J and Hittel
DS: Myostatin-induced inhibition of the long noncoding RNA Malat1
is associated with decreased myogenesis. Am J Physiol Cell Physiol.
304:C995–C1001. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Michalik KM, You X, Manavski Y,
Doddaballapur A, Zörnig M, Braun T, John D, Ponomareva Y, Chen W,
Uchida S, et al: Long noncoding RNA MALAT1 regulates endothelial
cell function and vessel growth. Circ Res. 114:1389–1397. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yoshimoto R, Mayeda A, Yoshida M and
Nakagawa S: MALAT1 long non-coding RNA in cancer. Biochim Biophys
Acta. 1859:192–199. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Uchida S and Dimmeler S: Long noncoding
RNAs in cardiovascular diseases. Circ Res. 116:737–750. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang X, Tang X, Liu K, Hamblin MH and Yin
KJ: Long noncoding RNA malat1 regulates cerebrovascular pathologies
in ischemic stroke. J Neurosci. 37:1797–1806. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Vergadi E, Vaporidi K and Tsatsanis C:
Regulation of endotoxin tolerance and compensatory
anti-inflammatory response syndrome by Non-coding RNAs. Front
Immunol. 9:27052018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yang H, Liang N, Wang M, Fei Y, Sun J, Li
Z, Xu Y, Guo C, Cao Z, Li S and Jiao Y: Long noncoding RNA MALAT-1
is a novel inflammatory regulator in human systemic lupus
erythematosus. Oncotarget. 8:77400–77406. 2017.PubMed/NCBI
|
|
21
|
Shaker OG, Mahmoud RH, Abdelaleem OO,
Ibrahem EG, Mohamed AA, Zaki OM, Abdelghaffar NK, Ahmed TI, Hemeda
NF, Ahmed NA and Mansour DF: LncRNAs, MALAT1 and lnc-DC as
potential biomarkers for multiple sclerosis diagnosis. Biosci Rep.
39:BSR201813352019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Pan F, Zhu L, Lv H and Pei C: Quercetin
promotes the apoptosis of fibroblast-like synoviocytes in
rheumatoid arthritis by upregulating lncRNA MALAT1. Int J Mol Med.
38:1507–1514. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tano K, Mizuno R, Okada T, Rakwal R,
Shibato J, Masuo Y, Ijiri K and Akimitsu N: MALAT-1 enhances cell
motility of lung adenocarcinoma cells by influencing the expression
of motility-related genes. FEBS Lett. 584:4575–4580. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Huang C, Han J, Wu Y, Li S, Wang Q, Lin W
and Zhu J: Exosomal MALAT1 derived from oxidized low-density
lipoprotein-treated endothelial cells promotes M2 macrophage
polarization. Mol Med Rep. 18:509–515. 2018.PubMed/NCBI
|
|
26
|
Gao F, Chen R, Xi Y, Zhao Q and Gao H:
Long noncoding RNA MALAT1 regulates sepsis in patients with burns
by modulating miR-214 with TLR5. Mol Med Rep. 19:3756–3766.
2019.PubMed/NCBI
|
|
27
|
Shaker OG, Abdelaleem OO, Mahmoud RH,
Abdelghaffar NK, Ahmed TI, Said OM and Zaki OM: Diagnostic and
prognostic role of serum miR-20b, miR-17-3p, HOTAIR, and MALAT1 in
diabetic retinopathy. IUBMB Life. 71:310–320. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang B, Arun G, Mao YS, Lazar Z, Hung G,
Bhattacharjee G, Xiao X, Booth CJ, Wu J, Zhang C and Spector DL:
The lncRNA Malat1 is dispensable for mouse development but its
transcription plays a cis-regulatory role in the adult. Cell Rep.
2:111–123. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen H, Wang X, Yan X, Cheng X, He X and
Zheng W: LncRNA MALAT1 regulates sepsis-induced cardiac
inflammation and dysfunction via interaction with miR-125b and p38
MAPK/NFkB. Int Immunopharmacol. 55:69–76. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yu Z, Rayile A, Zhang X, Li Y and Zhao Q:
Ulinastatin protects against lipopolysaccharide-induced cardiac
microvascular endothelial cell dysfunction via downregulation of
lncRNA MALAT1 and EZH2 in sepsis. Int J Mol Med. 39:1269–1276.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Dai L, Zhang G, Cheng Z, Wang X, Jia L,
Jing X, Wang H, Zhang R, Liu M, Jiang T, et al: Knockdown of LncRNA
MALAT1 contributes to the suppression of inflammatory responses by
up-regulating miR-146a in LPS-induced acute lung injury. Connect
Tissue Res. 59:581–592. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ding Y, Guo F, Zhu T, Li J, Gu D, Jiang W,
Lu Y and Zhou D: Mechanism of long non-coding RNA MALAT1 in
lipopolysaccharide-induced acute kidney injury is mediated by the
miR-146a/NF-κB signaling pathway. Int J Mol Med. 41:446–454.
2018.PubMed/NCBI
|
|
33
|
Pan L, Liu D, Zhao L, Wang L, Xin M and Li
X: Long noncoding RNA MALAT1 alleviates lipopolysaccharide-induced
inflammatory injury by upregulating microRNA-19b in murine
chondrogenic ATDC5 cells. J Cell Biochem. 119:10165–10175. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Gast M, Rauch BH, Nakagawa S, Haghikia A,
Jasina A, Haas J, Nath N, Jensen L, Stroux A, Böhm A, et al: Immune
system-mediated atherosclerosis caused by deficiency of long
non-coding RNA MALAT1 in ApoE-/-mice. Cardiovasc Res. 115:302–314.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhao G, Su Z, Song D, Mao Y and Mao X: The
long noncoding RNA MALAT1 regulates the lipopolysaccharide-induced
inflammatory response through its interaction with NF-κB. FEBS
Lett. 590:2884–2895. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Castelli GP, Pognani C, Cita M, Stuani A,
Sgarbi L and Paladini R: Procalcitonin, C-reactive protein, white
blood cells and SOFA score in ICU: Diagnosis and monitoring of
sepsis. Minerva Anestesiol. 72:69–80. 2006.PubMed/NCBI
|
|
37
|
Dahaba AA and Metzler H: Procalcitonin's
role in the sepsis cascade. Is procalcitonin a sepsis marker or
mediator? Minerva Anestesiol. 75:447–452. 2009.PubMed/NCBI
|
|
38
|
Tian X and Xu G: Clinical value of lncRNA
MALAT1 as a prognostic marker in human cancer: Systematic review
and meta-analysis. BMJ Open. 5:e0086532015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zeng Q, Wu J and Yang S: Circulating
lncRNA ITSN1-2 is upregulated, and its high expression correlates
with increased disease severity, elevated inflammation, and poor
survival in sepsis patients. J Clin Lab Anal. 33:e228362019.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Huang Q, Huang C, Luo Y, He F and Zhang R:
Circulating lncRNA NEAT1 correlates with increased risk, elevated
severity and unfavorable prognosis in sepsis patients. Am J Emerg
Med. 36:1659–1663. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
American college of chest
physicians/society of critical care medicine consensus conference,
. Definitions for sepsis and organ failure and guidelines for the
use of innovative therapies in sepsis. Crit Care Med. 20:864–874.
1992. View Article : Google Scholar : PubMed/NCBI
|
